巴西绿蜂胶对糖尿病患者生化指标及饮食摄入的影响。

IF 6.1 3区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Gabriela Fonseca Lopes , Paula Brumana Corrêa , Fernando Luiz Pereira de Oliveira , Nathalia Sernizon Guimarães , Nícia Pedreira Soares , Andrea Yukie Arikawa , Aline da Silva Miranda de Menezes e Souza , Rachel Basques Caligiorne , Luciana Araújo Marques , Nancy Scardua Binda , Sônia Maria de Figueiredo
{"title":"巴西绿蜂胶对糖尿病患者生化指标及饮食摄入的影响。","authors":"Gabriela Fonseca Lopes ,&nbsp;Paula Brumana Corrêa ,&nbsp;Fernando Luiz Pereira de Oliveira ,&nbsp;Nathalia Sernizon Guimarães ,&nbsp;Nícia Pedreira Soares ,&nbsp;Andrea Yukie Arikawa ,&nbsp;Aline da Silva Miranda de Menezes e Souza ,&nbsp;Rachel Basques Caligiorne ,&nbsp;Luciana Araújo Marques ,&nbsp;Nancy Scardua Binda ,&nbsp;Sônia Maria de Figueiredo","doi":"10.1016/j.diabres.2025.112236","DOIUrl":null,"url":null,"abstract":"<div><div><strong><em>Objective:</em></strong> To evaluate the effect of dietary supplementation with Brazilian green propolis-BrGrProp on biochemical parameters and dietary intake in People Living with Diabetes − PLWD. <strong><em>Method:</em></strong> Randomized double-blind study performed for thirty days. PLWD (n = 62/Phase-1: PLWD supplemented with BrGrProp (<strong>G1/</strong>n = 31) and another treated with <em>Manihot esculenta</em> starch (Placebo/n = 31). From this group, 22 PLWD (<strong>G2</strong>) participated in the study being treated with BrGrProp, characterized as Phase-2. PLWD received capsules (2× 500 mg/day) of BrGrProp or Placebo. Fasting blood glucose, glycated hemoglobin (HbA1c), total cholesterol and fractions, pyruvic glutamic transaminase, oxalacetic glutamic transaminase, gamma glutamyl transferase, and dietary intake data were determined at the beginning and end of the study. Statistical analysis was performed using the SPSS 21/Minitab-17/Prisma 7.0. <strong><em>Results:</em></strong> Phase-1: no significant changes were observed in the analyzed parameters. Phase 2: Improvement in glycemic parameters (FBG and HbA1c) and most lipid parameters (TC, LDL, HDL and TG), with reduction in the level of Hb1Ac (p = 0.023), increase in the level of HDL (p = 0.048) and in the food intake of the PLWD. The indicators of liver function did not show significant changes. <strong><em>Conclusion:</em></strong> BrGrProp in the diet generates beneficial effects for diabetics, characterized by improvement of HbA1c and HDL parameters, without causing detectable harmful changes.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"225 ","pages":"Article 112236"},"PeriodicalIF":6.1000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Brazilian green propolis effect on biochemical parameters and dietary intake in people living with diabetes\",\"authors\":\"Gabriela Fonseca Lopes ,&nbsp;Paula Brumana Corrêa ,&nbsp;Fernando Luiz Pereira de Oliveira ,&nbsp;Nathalia Sernizon Guimarães ,&nbsp;Nícia Pedreira Soares ,&nbsp;Andrea Yukie Arikawa ,&nbsp;Aline da Silva Miranda de Menezes e Souza ,&nbsp;Rachel Basques Caligiorne ,&nbsp;Luciana Araújo Marques ,&nbsp;Nancy Scardua Binda ,&nbsp;Sônia Maria de Figueiredo\",\"doi\":\"10.1016/j.diabres.2025.112236\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><strong><em>Objective:</em></strong> To evaluate the effect of dietary supplementation with Brazilian green propolis-BrGrProp on biochemical parameters and dietary intake in People Living with Diabetes − PLWD. <strong><em>Method:</em></strong> Randomized double-blind study performed for thirty days. PLWD (n = 62/Phase-1: PLWD supplemented with BrGrProp (<strong>G1/</strong>n = 31) and another treated with <em>Manihot esculenta</em> starch (Placebo/n = 31). From this group, 22 PLWD (<strong>G2</strong>) participated in the study being treated with BrGrProp, characterized as Phase-2. PLWD received capsules (2× 500 mg/day) of BrGrProp or Placebo. Fasting blood glucose, glycated hemoglobin (HbA1c), total cholesterol and fractions, pyruvic glutamic transaminase, oxalacetic glutamic transaminase, gamma glutamyl transferase, and dietary intake data were determined at the beginning and end of the study. Statistical analysis was performed using the SPSS 21/Minitab-17/Prisma 7.0. <strong><em>Results:</em></strong> Phase-1: no significant changes were observed in the analyzed parameters. Phase 2: Improvement in glycemic parameters (FBG and HbA1c) and most lipid parameters (TC, LDL, HDL and TG), with reduction in the level of Hb1Ac (p = 0.023), increase in the level of HDL (p = 0.048) and in the food intake of the PLWD. The indicators of liver function did not show significant changes. <strong><em>Conclusion:</em></strong> BrGrProp in the diet generates beneficial effects for diabetics, characterized by improvement of HbA1c and HDL parameters, without causing detectable harmful changes.</div></div>\",\"PeriodicalId\":11249,\"journal\":{\"name\":\"Diabetes research and clinical practice\",\"volume\":\"225 \",\"pages\":\"Article 112236\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2025-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes research and clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168822725002505\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725002505","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:评价日粮中添加巴西绿蜂胶- brgrprop对糖尿病- PLWD患者生化指标和膳食摄入量的影响。方法:随机双盲研究30天。PLWD (n = 62/第一阶段:PLWD补充BrGrProp (G1/n = 31),另一组使用Manihot esculenta淀粉(安慰剂/n = 31)。该组22例PLWD (G2)患者接受BrGrProp治疗,为第2期。PLWD接受BrGrProp胶囊(2× 500 mg/天)或安慰剂。在研究开始和结束时测定空腹血糖、糖化血红蛋白(HbA1c)、总胆固醇及其组分、丙酮谷氨转氨酶、草酸乙酸谷氨转氨酶、γ谷氨酰转移酶和饮食摄入数据。采用SPSS 21/Minitab-17/Prisma 7.0进行统计学分析。结果:第一阶段:分析参数未见明显变化。第2阶段:血糖参数(FBG和HbA1c)和大部分脂质参数(TC、LDL、HDL和TG)改善,其中Hb1Ac水平降低(p = 0.023),HDL水平升高(p = 0.048),PLWD的进食量增加。肝功能指标未见明显变化。结论:BrGrProp在饮食中对糖尿病患者有有益作用,其特点是改善HbA1c和HDL参数,但未引起可检测到的有害变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Brazilian green propolis effect on biochemical parameters and dietary intake in people living with diabetes
Objective: To evaluate the effect of dietary supplementation with Brazilian green propolis-BrGrProp on biochemical parameters and dietary intake in People Living with Diabetes − PLWD. Method: Randomized double-blind study performed for thirty days. PLWD (n = 62/Phase-1: PLWD supplemented with BrGrProp (G1/n = 31) and another treated with Manihot esculenta starch (Placebo/n = 31). From this group, 22 PLWD (G2) participated in the study being treated with BrGrProp, characterized as Phase-2. PLWD received capsules (2× 500 mg/day) of BrGrProp or Placebo. Fasting blood glucose, glycated hemoglobin (HbA1c), total cholesterol and fractions, pyruvic glutamic transaminase, oxalacetic glutamic transaminase, gamma glutamyl transferase, and dietary intake data were determined at the beginning and end of the study. Statistical analysis was performed using the SPSS 21/Minitab-17/Prisma 7.0. Results: Phase-1: no significant changes were observed in the analyzed parameters. Phase 2: Improvement in glycemic parameters (FBG and HbA1c) and most lipid parameters (TC, LDL, HDL and TG), with reduction in the level of Hb1Ac (p = 0.023), increase in the level of HDL (p = 0.048) and in the food intake of the PLWD. The indicators of liver function did not show significant changes. Conclusion: BrGrProp in the diet generates beneficial effects for diabetics, characterized by improvement of HbA1c and HDL parameters, without causing detectable harmful changes.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes research and clinical practice
Diabetes research and clinical practice 医学-内分泌学与代谢
CiteScore
10.30
自引率
3.90%
发文量
862
审稿时长
32 days
期刊介绍: Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信